First elected: 4th July 2024
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
e-Petitions are administered by Parliament and allow members of the public to express support for a particular issue.
If an e-petition reaches 10,000 signatures the Government will issue a written response.
If an e-petition reaches 100,000 signatures the petition becomes eligible for a Parliamentary debate (usually Monday 4.30pm in Westminster Hall).
These initiatives were driven by Danny Beales, and are more likely to reflect personal policy preferences.
MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.
Danny Beales has not been granted any Urgent Questions
Danny Beales has not been granted any Adjournment Debates
Danny Beales has not introduced any legislation before Parliament
Danny Beales has not co-sponsored any Bills in the current parliamentary sitting
The impact of the Employment Rights Bill on those individuals will depend largely on their employment status. Individuals in the platform economy can be any status: employee, limb (b) worker, or self-employed, depending on the reality of the relationship between them and their employer.
The Employment Rights Bill, once implemented, will represent the biggest upgrade of workers’ rights in a generation. It will raise the minimum floor of employment rights, raise living standards across the country and level the playing field for those businesses who are engaged in good practices.
Enforcement powers exist for local authorities to take action when fireworks are unsafe, sold illegally or misused. Local authorities and the police also have powers to tackle anti-social behaviour caused by the misuse of fireworks. It is for local areas to decide how best to deploy these powers, based on their specific circumstances.
To inform any future decisions I intend to engage with businesses, consumer groups and charities shortly after the fireworks season to gather evidence on the issues and impacts of fireworks.
Net zero will bring significant opportunities to people across the UK such as greater energy security, economic opportunities and good jobs. The Government is committed to bringing people with it on the transition to net zero, empowering them to take action and demonstrating the benefits of the transition. We have also committed to the Warm Homes Plan which will transform homes, making them cheaper and cleaner to run, full details of this will be set out next Spring.
Net zero will bring significant opportunities to people across the UK such as greater energy security, economic opportunities and good jobs. The Government is committed to bringing people with it on the transition to net zero, empowering them to take action and demonstrating the benefits of the transition. We have also committed to the Warm Homes Plan which will transform homes, making them cheaper and cleaner to run, full details of this will be set out next Spring.
Government has committed to developing an ambitious Industrial Strategy in partnership with business, devolved governments, regions and other stakeholders. This includes universities, who play a key role in driving local and national economic growth – in 2023, UK university spinouts raised £1.66 billion in equity funding, 9.5% of all equity funding raised by UK companies.
The Government believes that the current list of events works well and that it strikes an appropriate balance between access to sporting events and allowing sports to maximise broadcasting revenue. Therefore, the Government has no plans to review the list at this time.
It is right that the Rugby Football Union (RFU) and Six Nations Rugby take a considered and balanced approach: recognising the need to achieve reach with existing and new fans, the importance that the Six Nations has for the cultural pride of each of the Home Nations, all the while maximising broadcast revenue.
The Government believes that the current list of events works well and that it strikes an appropriate balance between access to sporting events and allowing sports to maximise broadcasting revenue. Therefore, the Government has no plans to review the list at this time.
It is right that the Rugby Football Union (RFU) and Six Nations Rugby take a considered and balanced approach: recognising the need to achieve reach with existing and new fans, the importance that the Six Nations has for the cultural pride of each of the Home Nations, all the while maximising broadcast revenue.
The department is due to announce outstanding policy details related to the Lifelong Learning Entitlement later this year. These details will inform our demand projections for this specific programme, and we will share further information about this in due course.
This government recognises the importance and value of investing and creating a culture of lifelong learning in our country to support our industrial strategy and economic growth. This starts with activity already underway, such as the independent Curriculum and Assessment Review, establishing Skills England, utilising local skills improvement plans, further supporting skills bootcamps and apprenticeships and devolving the adult skills fund to support learning and development in all stages of life.
This government is committed to improving mental health support for all children and young people. This is critical to high and rising standards in schools and breaking down barriers to opportunity, helping pupils to achieve and thrive in education.
The government will deliver on this commitment through providing access to specialist mental health professionals in every school, so every young person has access to early support to address problems before they escalate.
As of April 2024, NHS-funded Mental Health Support Teams covered 44% of pupils in schools and learners in further education in England, and are expected to cover at least 50% by the end of March 2025.
The department will also be putting in place new Young Futures hubs, including access to mental health support workers, and will recruit an additional 8,500 new mental health staff to treat children and adults.
To support education staff, the department provides a range of guidance and practical resources on promoting and supporting pupils’ mental health and wellbeing, such as a resources hub for mental health leads and a toolkit to help schools choose evidence-based early support for pupils.
On top of this, schools are also able to arrange their own mental health interventions that are best suited to their pupils using the core revenue and pupil premium funding they receive from the department.
The Autumn Budget 2024 confirmed an additional £2.3 billion for the core schools budget for 2025/26 compared to 2024/25. This means that overall core schools funding will reach over £63.9 billion in 2025/26.
The government is taking several steps to make it easier for adults to access training. The Adult Skills Fund (ASF) fully or co-funds education and skills training for eligible adults aged 19 and above from pre-entry to level 3, to help them gain the skills they need for work, an apprenticeship or further learning.
Currently, approximately 60% of the ASF is devolved to nine Mayoral Combined Authorities and the Greater London Authority. These authorities are responsible for deciding what provision and support to offer their residents, allowing them the flexibility to respond to local needs.
The department is developing new foundation apprenticeships to give more people a foot in the door of work, whilst supporting the pipeline of new talent that employers will need to drive economic growth. Skills Bootcamps also continue to be funded and are available across England, giving adults the chance to build sector-specific skills, including in digital, construction and green industries, with an offer of a job interview on completion.
Lastly, in the 2026/2027 academic year, the department is also introducing the Lifelong Learning Entitlement (LLE). The LLE will transform the post-18 student finance system by allowing people to develop new skills and gain new qualifications at a time that is right for them. From September 2026, learners will be able to apply for LLE funding for the first time for courses and modules starting from January 2027 onwards. From its launch, the LLE loan will be available for full courses at level 4 to 6, such as a degrees, technical qualifications, designated distance-learning and online courses, and modules of high value technical courses at level 4 to 5.
Under the LLE, eligible learners will be able to access a tuition fee loan, with new learners able to access up to the full entitlement of £38,140, equal to four years of study based on the 2025/ 2026 academic year fee rates, and a maintenance loan to cover living costs, for courses with in-person attendance. Ultimately, this will enable individuals to learn, upskill, and retrain across their entire lives.
The Environment Agency works with the water industry on the Chemicals Investigation Programme (CIP). This is funded through the water industry price review and considers chemicals in sewage effluent, including some pharmaceuticals and Per- and polyfluoroalkyl substances (PFAS). The fourth CIP has just started.
Regulation does not currently cover microplastics from treated wastewater. 99% of microplastics are removed by sewage treatment processes. The EA and water industry are commencing six investigations under CIP considering generation of microplastics within wastewater treatment works through attrition of plastic equipment, emerging sewage treatment technologies and path of microplastics from biosolids applied to land to soils and groundwater.
The EA sits on the Pharmaceuticals in the Environment Group. Pharmaceuticals are not required to undergo an environmental impact assessment, but a few have ecotoxicological thresholds that inform an assessment of potential risk. The EA Is currently investigating potential ecological risks of mixtures of pharmaceuticals in the aquatic environment.
CIP4 is looking at PFAS from wastewater treatment works. CIP2 identified domestic sewage as a significant source of PFAS. On-going work includes identifying sources of or Perfluorooctanesulfonic Acid (PFOS), a type of PFAS, in catchments to inform approaches to permitting discharges, and to reduce/eliminate PFOS at source.
The Government is in close contact with counterparts in the United States on the incidents of influenza of avian origin in cattle in the USA. We know that the strain of virus (Highly Pathogenic Avian Influenza (HPAI) strain B3.13) involved has not been detected in the UK from our bulk milk testing and wider surveillance.
Defra is working closely with the Department of Health and Social Care (DHSC), the UK Health Security Agency (UKHSA), the Food Standards Agency (FSA), the Cabinet Office and with international partners to consider the potential routes of incursion, evidence of animal-to-animal spread and risks of animal-to-human spillover and to reviewed our well-tested surveillance and preparedness activities to detect and respond to any infection of cattle from influenza of avian origin in the future.
The Animal and Plant Health Agency (APHA) has assessed the risk to livestock in Great Britain from this outbreak of Influenza A (H5N1) of avian origin in livestock in the USA, as very low (event is very rare but cannot be excluded) (Avian influenza in cattle in USA (publishing.service.gov.uk). The FSA have assessed the risk to UK consumers from HPAI strain B3.13 in imported milk, dairy products, colostrum and colostrum-based products originating from US dairy cattle as very low with medium uncertainty (Rapid Risk Assessment: Risk to UK consumers from Highly Pathogenic Avian Influenza (HPAI) H5N1 B3.13 in US dairy products | Food Standards Agency). The Human Animal Infections and Risk Surveillance group (HAIRS) consider that the HPAI B3.13 strain presents at most a very low risk with regard to spread from animals-to-humans in the UK HAIRS risk statement: Avian influenza A(H5N1) in livestock - GOV.UK (www.gov.uk).
Defra has funded a research consortium at led by The Pirbright Institute and Imperial College to understand this unusual situation. In addition, we have published an Influenza A (H5N1) infection in mammals: suspect case definition and diagnostic testing criteria’ on gov.uk to support veterinary professionals and others in knowing when to report suspicion.
The cross-Government Motor Insurance Taskforce met for the first time on 16 October 2024 and the Secretary of State is keen to reconvene again soon.
The Taskforce has a strategic remit to set the direction for UK Government policy, identifying short- and long-term actions for departments that may contribute to stabilising or reducing premiums, while maintaining appropriate levels of cover. It will look at the increased insurance costs on consumers and the insurance industry, including how this impacts different demographics, geographies, and communities.
We will provide updates on the Taskforce in due course.
The Government is urgently exploring options to crack down on the spiralling cost of motor insurance and continues to engage with representatives of the motor insurance industry to understand the causes of increased premiums and identify potential solutions. We will announce the next steps in due course.
The Government is urgently exploring options to crack down on the spiralling cost of motor insurance and continues to engage with representatives of the motor insurance industry to understand the causes of increased premiums and identify potential solutions. We will announce the next steps in due course.
The Youth Guarantee Trailblazers will test a new, more localised delivery framework to help young people access education, training and employment support, providing important learnings to inform the future development of the Youth Guarantee in England.
The Department for Work and Pensions and the Department for Education are working closely with Mayoral Strategic Authorities to begin delivery of Youth Guarantee Traiblazers in the following areas: the West of England, Tees Valley, East Midlands, Cambridgeshire and Peterborough, Liverpool City Region, West Midlands and two areas within the Greater London Authority. This will include parts of West London.
As announced in the “Get Britain Working” White Paper, we are launching a new Youth Guarantee for all young people aged 18-21 in England to ensure that they can access quality training opportunities, an apprenticeship or help to find work. The Youth Guarantee will build upon and enhance existing entitlements and provisions with the aim of tackling the rising number of young people who are not participating in education, employment or training. This spring we will be launching trailblazers in eight Mayoral Strategic Authorities, one of which is the Greater London Authority, and will use the learning from the Trailblazers to inform the future design and development of the Youth Guarantee as it rolls-out across the rest of England.
The additional employment, and education and training in which young people will participate, as a result of the Youth Guarantee, will bring economic benefits to the young people themselves and to wider society through earnings, economic output and through increased skills which open the way to longer term sustained employment.
The Get Britain Working White Paper published in November set out plans to deliver fundamental reform of our health, employment and skills system, that will help support economically inactive people in all areas in England get back into work.
We committed to:
The Greater London area will host several Trailblazers, covering both inactivity and youth. This will involve working closely with a range of local partners, including those based in West London. Additional funding will also be given to the Greater London Authority to support the development of their local Get Britain Working plan, to cover the four sub-regional London partnership areas delivering Connect to Work.
The Department for Work and Pensions are supporting many young people with Special Educational Needs and Disabilities (SEND) to find employment.
The government will be launching a Youth Guarantee for all 18-21 year olds in England, to ensure that they can access quality training opportunities, an apprenticeship or help to find work. This will start with eight trailblazers, which are launching this spring, and testing localised approaches to supporting young people, which could include those with SEND.
Delivering our manifesto commitment to tackle child poverty is an urgent priority for this Government, and the Ministerial Taskforce is working to publish the Child Poverty Strategy in Spring 2025.
The Taskforce’s publication of 23 October ‘Tackling Child Poverty: Developing our Strategy’ sets out how we are developing the Strategy, exploring all available levers across Government to deliver an enduring reduction in child poverty this parliament. This is part of a 10-year strategy for lasting change which will be published in the Spring.
The Strategy will look at levers across four key themes of increasing incomes, reducing essential costs, increasing financial resilience; and better local support especially in the early years. This will build on the reform plans underway across government and work underway in Devolved Governments.
The Taskforce will hear directly from experts on each of the Strategy’s themes including children and families living in poverty and work with leading organisations, charities, and campaigners. In December, the Taskforce met with external experts from the housing sector to discuss the critical role of housing in tackling child poverty. The Ministerial session was the first in a series of deep dives into specific policy areas; the focus of this session was on parental employment, childcare and housing.
The 10-Year Health Plan will deliver the three big shifts our National Health Service needs to be fit for the future: from hospital to community; from analogue to digital; and from sickness to prevention. All of these are relevant to improving respiratory health in all parts of the county.
More tests and scans delivered in the community to allow for earlier diagnosis, better joint working between services, and greater use of apps and wearable technology will all help people manage their long-term conditions, including respiratory conditions, closer to home. Earlier diagnosis of conditions will help people manage their conditions, prevent deterioration, and improve survival rates. Taking action to reduce the causes of the biggest killers, such as enabling a smoke free generation, can further help prevent lung conditions.
Through the Life Sciences Sector Plan and the wider industrial strategy, the Government will take targeted, concerted, and aggressive action to unlock growth. The plan will focus on enabling world-class research and development, making the United Kingdom one of the best places in the world to start, scale, and invest in life sciences, and driving healthcare innovation and reform. This approach will support high-growth businesses, deliver better health outcomes, and cement the UK’s global leadership in life sciences. Backed by deep engagement with industry, the plan will tackle barriers head-on and lay the foundations for long-term, sustainable growth.
The reforms to Part IX of the Drug Tariff and the National Institute for Health and Care Excellence’s (NICE) late-stage assessments align with this approach by supporting the adoption of innovation. The Part IX reforms include a new two-year temporary listing mechanism so that innovative products can be made available for patients more quickly. The NICE’s late-stage assessments are a central element of the NICE’s lifecycle approach to evaluation, valuing incremental innovation in transformative products once they have become established or widely available to the National Health Service. The assessments will provide guidance on value, especially where there are claims of improvements and innovation over time, to support NHS commissioners, procurement teams, patients, and clinicians to select the most effective and cost-effective products, from those available on the market.
The Department commissions the National Institute for Health and Care Excellence (NICE) to undertake Late-Stage Assessments (LSAs) to help commissioners, clinicians, and patients identify the most effective products that offer the best value for the National Health Service.
The NICE’s LSA of intermittent urethral catheters for chronic incomplete bladder emptying focuses on urethral catheters used in primary care and community settings. This will ensure that as more healthcare is delivered in community settings, commissioners, clinicians, and patients will be better informed when identifying the most effective and best value for money intermittent catheters in a crowded market.
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new, licenced medicines represent a clinically and cost-effective use of resources. The NHS in England is legally required to fund medicines recommended by the NICE for eligible patients in line with its recommendations.
The NICE has published guidance recommending abiraterone for the treatment of metastatic hormone-relapsed prostate cancer before chemotherapy is indicated and for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen. NHS England funds abiraterone for these indications of prostate cancer in line with the NICE’s recommendations, making it routinely available for clinicians to prescribe to eligible patients.
NHS England considered abiraterone as an off-label treatment for hormone sensitive, non-metastatic prostate cancer through its clinical policy development process in 2024/25. Through this process, NHS England confirmed that there was sufficient supporting evidence to support the routine commissioning of abiraterone in this indication and it was ranked in the highest priority level. However, NHS England could not identify the necessary recurrent funding to support commissioning of abiraterone, or any other treatments within the prioritisation round. Ministers are considering further advice on this issue.
The Government understands that more needs to be done to improve outcomes for all people with prostate cancer.
To address disparities and find ways to better detect prostate cancer earlier, we have invested £16 million in the United Kingdom-wide TRANSFORM trial, aimed at helping find the best ways of detecting prostate cancer in men, even if they are not displaying any symptoms. This research will aim to address some of the inequalities that exist in prostate cancer diagnosis by targeting black men in trial recruitment, ensuring that one in ten participants are black men. We have also asked the National Screening Committee to review the evidence for prostate cancer screening, including for high-risk groups.
The NHS England Cancer Programme also commissions clinical cancer audits, which provide timely evidence for cancer service providers of where patterns of care in England may vary, increase the consistency of access to treatments, and help stimulate improvements in cancer treatment and outcomes for patients, including those with prostate cancer.
Following publication of the 10-Year Health Plan, we will develop a new National Cancer Plan. The plan will seek to improve outcomes and address disparities for all cancers, including for prostate cancer. A call for evidence, seeking contributions from individuals and organisations, including ideas on how to improve outcomes and reduce inequalities for prostate cancer, is available at the following link:
The Department commissioned the National Institute for Health and Care Excellence (NICE) to undertake Late-Stage Assessments (LSAs) to help commissioners, clinicians, and patients identify the most effective products that offer the best value for the National Health Service. LSAs benefit health technology manufacturers by giving all manufacturers a transparent, robust, and evidence-based process for demonstrating the added value of their products.
The Department is working closely with industry through the Drug Tariff Committee to finalise the detail of the update to the product categorisation and listing process of Part IX of the Drug Tariff. The Department remains committed to ensuring that the reforms represent a positive change for patients, the National Health Service, and the medical technology sector. For example, to support innovation and inward investment, a new two-year temporary listing mechanism will be introduced so that innovative products can be made available for patients more quickly.
Through the Life Sciences Sector Plan and the wider industrial strategy, the Government will take targeted, concerted, and aggressive action to unlock growth. The plan will focus on enabling world-class research and development, making the United Kingdom one of the best places in the world to start, scale, and invest in life sciences, and driving healthcare innovation and reform. This approach will support high-growth businesses, deliver better health outcomes, and cement the UK’s global leadership in life sciences. Backed by deep engagement with industry, the plan will tackle barriers head-on and lay the foundations for long-term, sustainable growth.
The reforms to Part IX of the Drug Tariff and the National Institute for Health and Care Excellence’s (NICE) late-stage assessments align with this approach by supporting the adoption of innovation. The Part IX reforms include a new two-year temporary listing mechanism so that innovative products can be made available for patients more quickly. The NICE’s late-stage assessments are a central element of the NICE’s lifecycle approach to evaluation, valuing incremental innovation in transformative products once they have become established or widely available to the National Health Service. The assessments will provide guidance on value, especially where there are claims of improvements and innovation over time, to support NHS commissioners, procurement teams, patients, and clinicians to select the most effective and cost-effective products, from those available on the market.
It is unacceptable that there are such stark inequalities for women and babies. It is a priority for the Government to make sure that all women and babies receive the high-quality care they deserve, regardless of their background, location, or ethnicity.
We are supporting NHS England as it delivers its three-year plan to make maternity and neonatal care more personalised, safe, compassionate, and equitable for women and babies. As part of this, all Local Maternity and Neonatal Systems are implementing their equity and equality actions plans, which include targeted interventions to tackle inequalities for women and babies from ethnic minorities and those living in the most deprived areas. All trusts are implementing version three of the Saving Babies Lives Care Bundle, which provides maternity units with guidance and interventions to reduce stillbirths, brain injuries, neonatal deaths, preterm births, and inequalities.
We are working closely with NHS England, and the wider sector, to identify further interventions to address inequalities for women and babies. Some of these will require time to implement, but we also need to ensure that there are immediate actions that can begin to drive forward improvements now. This includes the targets needed to drive change, in line with the Government’s commitment to setting an explicit target to close the black and Asian maternal mortality gaps.
The Government is committed to tackling the retention and recruitment challenges that face the National Health Service. Bringing in the staff we need will take time, but this is a priority for the Government.
NHS England is leading a range of initiatives to boost retention of existing staff and ensure that the NHS remains an attractive career choice for new recruits. This includes building a compassionate and inclusive culture, supporting staff wellbeing, and promoting flexible working opportunities. As a part of this, there are interventions in place specific to the maternity and neonatal workforce, such as creating a midwifery and nursing retention self-assessment tool, mentoring schemes, support on pensions, investing in unit-based midwife retention leads. We are also boosting the midwifery workforce through undergraduate training, apprenticeships, postgraduate conversion, and return to midwifery programmes.
To rebuild dentistry in the long term and increase access to National Health Service dental care, we will reform the dental contract, with a shift to focus on prevention and the retention of NHS dentists.
There are no perfect payment systems and careful consideration needs to be given to any potential changes to the complex dental system so that we deliver a system better for patients and the profession.
We continue to meet the British Dental Association and other representatives of the dental sector to discuss how we can best deliver our shared ambition to improve access for NHS dental patients.
The Government will provide access to specialist mental health professionals in every school through expanding Mental Health Support Teams, so every young person has access to early support to address problems before they escalate.
An assessment of the efficacy of booster vaccinations has not been made as there is currently no requirement for mpox booster vaccinations.
There is currently insufficient evidence to support routine boosters of mpox vaccination in immunocompetent individuals, namely people with the ability to produce a normal immune response; further information is contained in Smallpox and mpox: the green book, chapter 29, which is available at the following link:
https://www.gov.uk/government/publications/smallpox-and-vaccinia-the-green-book-chapter-29
The total number of Mpox vaccinations administered in England in the 2023/24 financial year totalled to 21,225. The total number of Mpox vaccinations administered in the 2024/25 financial year to date currently stands at 15,649.
The data was extracted on 5 February 2025 based on aggregate data submissions from sexual health or genitourinary medicine clinics. The data covers a period of 1 April 2023 to 31 March 2024, and 1 April 2024 to 31 January 2025.
The following table shows the number of Mpox vaccines delivered each month from 1 January 2024 to 31 January 2025, as well as the total Mpox vaccines delivered in that period:
Month | Number of Mpox vaccinations administered |
January 2024 | 804 |
February 2024 | 1,069 |
March 2024 | 900 |
April 2024 | 612 |
May 2024 | 899 |
June 2024 | 894 |
July 2024 | 704 |
August 2024 | 2,856 |
September 2024 | 2,078 |
October 2024 | 4,329 |
November 2024 | 1,713 |
December 2024 | 1,271 |
January 2025 | 293 |
Total | 18,422 |
The data was extracted on 5 February 2025 and is based on aggregate data submissions from sexual health or genitourinary medicine clinics.
NHS England is planning for a routine Mpox vaccination programme, whilst continuing to offer vaccination to eligible cohorts in areas with the highest density of the eligible population as part of the response to the recent Mpox outbreaks.
NHS England has recently opened additional Mpox vaccination sites across the country to support the access for eligible individuals, with further information available at the following link:
https://www.england.nhs.uk/2025/02/nhs-opens-new-mpox-vaccination-sites-across-england/
The programme will be delivered through Sexual Health Services who have experience in the assessment, identification, and vaccination of those who are at increased risk of Mpox infection.
This information is not held in the format requested. The total number of mpox vaccinations administered in England in 2023/24 financial year was 21,225. The total number of mpox vaccinations administered in 2024/25 financial year to date currently stands at 15,649. The latest vaccine coverage statistics are available at the following link:
https://www.gov.uk/government/collections/vaccine-uptake
Influenza and COVID-19 coverage data can also be viewed in the weekly flu and COVID-19 surveillance reports, which are available at the following link:
Childhood vaccination coverage statistics in England are available at the following link:
https://digital.nhs.uk/data-and-information/publications/statistical/nhs-immunisation-statistics
The Government is clear that patients should expect and receive the highest standard of service, and is determined to tackle the issue of corridor care.
Discussions on how to improve urgent and emergency care services are continuing, and we will continue to keep the data available and published to support that aim under review. Before the spring, we will set out the lessons learned from this winter and the improvements that we will put in place ahead of next winter.
The Government is clear that patients should expect and receive the highest standard of service, and is determined to tackle the issue of corridor care.
Discussions on how to improve urgent and emergency care services are continuing, including how best to make use of data. Before the spring, we will set out the lessons learned from this winter and the improvements that we will put in place ahead of next winter.
NHS England will continue to encourage the wider adoption of drone technology in the National Health Service where it is both feasible and appropriate.
The NHS is committed to decarbonising travel and transport, with a clear vision of achieving a zero-emission fleet by 2040. In October 2023, NHS England published the NHS Net Zero Travel and Transport Strategy, which contains an ambitious, yet deliverable, roadmap to achieve this. Further information on the NHS Net Zero Travel and Transport Strategy is available at the following link:
https://www.england.nhs.uk/publication/net-zero-travel-and-transport-strategy/
This strategy includes drones as one of the interventions to achieve decarbonised travel and transport. There have already been a number of projects testing and implementing the use of drone technology in the NHS, including pathology drones in Cornwall and blood delivery drones in London. Further information on the pathology drones in Cornwall and the blood delivery drones in London is available, respectively, at the following two links:
Drones have also been used to deliver vital chemotherapy to the Isle of Wight, reducing a four-hour journey time by road and sea to a 30-minute flight, minimising waste and treatment delays whilst also reducing carbon, with further information available at the following link:
The medical drone delivery service for the Guy's and St Thomas' NHS Foundation Trust is a six-month trial, that started in November. There is potential for drones to support and improve the way the National Health Service delivers patient care, with the outcome of trials supporting NHS trusts to consider the benefits of adoption.
Screening for prostate cancer is currently not recommended in the United Kingdom, due to the inaccuracy of the current best test Prostate Specific Antigen.
A UK National Screening Committee (UK NSC) review looking at whether to offer screening for prostate cancer is currently underway. This evidence review will cover modelling the clinical effectiveness and cost of several approaches to prostate cancer screening. This will include different potential ways of screening the whole population and targeted screening aimed at groups of people identified as being at higher-than-average risk, such as black men or men with a family history of cancer.
Once the modelling and evidence review are complete, it will be considered by the UK NSC. Subject to no further revisions being required, the UK NSC plans to look at the findings towards the end of 2025.
Further details of the UK NSC’s evidence review process are available at the following link:
Shingles vaccination was originally routinely offered as part of the national immunisation programme to those aged 70, using the Zostavax vaccine. In 2019, the Joint Committee on Vaccination and Immunisation (JCVI) recommended that the programme should be changed to offer the Shingrix vaccine routinely at 60 years of age, that those aged between 60 and 70 years old should also be offered the vaccine, and that individuals would require two doses of Shingrix to complete the course.
Based on JCVI advice, the Department, the UK Health Security Agency and NHS England decided that the programme would be implemented in phases, with the first phase being that between 1 September 2023 and 31 August 2028, those who reach 65 or 70 years old should be called in on or after their 65th or 70th birthday. The second phase would be that from 1 September 2028 to 31 August 2033, those who reach age 60 or 65 years old should be called in on or after their 60th or 65th birthday. From 1 September 2033 onwards, vaccination will be routinely offered to those turning 60 years of age on or after their 60th birthday.
The JCVI also recommended that all severely immunosuppressed individuals aged 50 years old and older should be eligible for shingles vaccination due to their higher risk of complications from shingles. This programme change was also implemented on 1 September 2023. These individuals have been prioritised as part of the early roll-out of the programme to ensure those who are most vulnerable are protected.
The following table shows the number of applicants, by the June deadline, to undergraduate nursing courses, for all domiciles, in England, each year from 2019 to 2024:
Year | Applicants |
2019 | 31,780 |
2020 | 37,990 |
2021 | 45,740 |
2022 | 43,170 |
2023 | 36,400 |
2024 | 33,560 |
Source: published by the Universities and Colleges Admissions Service (UCAS), available at the following link:
Final applicant numbers for the 2024 cycle will be published by UCAS before the end of the year. The drop in nursing applicants follows the unprecedented demand for healthcare courses during the COVID-19 pandemic, and the number of applicants continues to outstrip the places on offer. Nursing training places are competitive, and lead to an attractive and important career in the National Health Service.
We are working closely with NHS England, universities, and UCAS to ensure that everyone who wants to pursue a rewarding healthcare career in nursing has the support and opportunities to do so.
The Government values nurses and is committed to supporting them as a profession, and in their everyday working lives. The Government accepted the pay recommendations of the NHS Pay Review Body for 2024/25 in full, providing a 5.5% consolidated pay uplift for 2024/25, backdated to 1 April, to approximately 1.4 million staff in England. A significant amount of work has also gone into developing a set of non-pay recommendations on measures to support the Agenda for Change workforce. This includes specific recommendations on improving career progression for the nursing workforce.
Targeted retention work for nurses and midwives is also being undertaken by NHS England and led by the Chief Nursing Officer. This includes the introduction of a nursing and midwifery retention self-assessment tool, a national preceptorship framework which provides early career support for nurses and midwives, and mentoring schemes.
It is essential that all National Health Service staff, including nurses, can work in a supportive and compassionate environment that recognises and prioritises health and wellbeing. NHS England has a wide-ranging package of mental health and wellbeing support for all staff.
NHS England have piloted sight testing and the dispensing of glasses in special schools since 2021. Between April 2021 and August 2024 a total of 23,832 sight tests were provided.
There were a total of 9,909 pairs of glasses issued between April 2021 and August 2024 as part of the service. Between April 2021 and March 2024, 859 sight tests were recorded with another sight problem identified, 14,048 sight tests were recorded where there was either no previous history or previous history was unknown and 6,083 sight tests were recorded where there was a history of hospital-based eye care.
The legislation that will underpin the roll out of this service across the country was laid on 28 November 2024.
NHS England have piloted sight testing and the dispensing of glasses in special schools since 2021. Between April 2021 and August 2024 a total of 23,832 sight tests were provided.
There were a total of 9,909 pairs of glasses issued between April 2021 and August 2024 as part of the service. Between April 2021 and March 2024, 859 sight tests were recorded with another sight problem identified, 14,048 sight tests were recorded where there was either no previous history or previous history was unknown and 6,083 sight tests were recorded where there was a history of hospital-based eye care.
The legislation that will underpin the roll out of this service across the country was laid on 28 November 2024.
Palliative care services are included in the list of services an integrated care board (ICB) must commission. This promotes a more consistent national approach and supports commissioners in prioritising palliative and end of life care. To support ICBs in this duty, NHS England has published statutory guidance and service specifications.
Whilst the majority of palliative and end of life care is provided by National Health Service staff and services, we recognise the vital part that voluntary sector organisations, including hospices, also play in providing support to people at end of life and their loved ones.
The amount of funding each charitable hospice receives varies both within and between ICB areas. This will vary depending on demand in that ICB area but will also be dependent on the totality and type of palliative and end of life care provision from both NHS and non-NHS services, including charitable hospices, within each ICB area.
We, alongside key partners NHS England, will continue to proactively engage with our stakeholders, including the voluntary sector and independent hospices, on an ongoing basis, in order to understand the issues they face, and we will consider next steps on palliative and end of life care, including funding, in the coming months.
Improving sexual health services is a priority for the Government and it is important that we capture the views of stakeholders as we develop our 10-Year Health Plan. To support this, we have launched a national engagement exercise. This will be the biggest conversation in the National Health Service’s history. We want to hear from a wide range of individuals and organisations, including many sexual health stakeholders. Organisations are encouraged to log onto the online portal and submit a response by 2 December 2024. The online portal is available at the following link:
We have also published a Workshop in a Box that will support organisations to conduct their own local engagement activities. This is available from the community engagement tab on the abovementioned website from Monday 18 November 2024, with a request that partner organisations collate and upload their insights to the website by 14 February 2025.